Remote Care for CIED Patients in Korea

July 18, 2023 updated by: You Mi Hwang, Saint Vincent's Hospital, Korea

Quality and Satisfaction in CIED Remote Monitoring

This trial is for monitoring the quality and satisfaction of CIED patients who are naive with remote device monitoring.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Patient satisfaction (using questionnaire) before and after wireless/wired monitoring and outpatient treatment time, variables in heart transplantation devices for wireless/wired monitoring, presence of heart failure, cardiovascular events such as arrhythmia, myocardial infarction or cerebral infarction, thromboembolism and admission related to cardiovascular cause. The questionnaire was adopted and modified from modified Korean version of HoMASQ (by YouMi Hwang,2021 from HoMASQ; Europace (2010))

Study Type

Observational

Enrollment (Actual)

102

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kyonggi Do
      • Suwon, Kyonggi Do, Korea, Republic of, 16247
        • St. Vincent's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 110 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

This study includes Biotronic CIED implanted patients in St. Vincent's Hospital, Catholic University of Korea, Republic of Korea. Study population are included if they are more than 20year old, followed up at outpatient clinic > 6 months after CIED implantation, and are literate and have perceptibility on questionnaire.

Description

Inclusion Criteria:

  1. Patients with Biotronic CIED implanted in St. Vincent's Hospital, Catholic University of Korea, Republic of Korea
  2. Patients who are literate and have perceptibility on questionnaire
  3. Patients who followed up more than 6 months after CIED implantation
  4. Patients with age of >20 years

Exclusion Criteria:

  1. Patients with < 2 outpatient clinic visits during >6 months
  2. Illiterate patients or inapprehensive of questionnaire
  3. Patients with life expectancy of <1 year

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction measurement before and after remote monitoring
Time Frame: 1 year
Satisfaction measurement by questionnaire: Survey on telehealth patient experience(modified Korean version by YouMi Hwang,2020 from Bas-Villalobos, Form I) and Post remote monitoring satisfaction questionnaire, modified Korean version by YouMi Hwang,2020 from HoMASQ (Home Monitoring Acceptance and Satisfaction Questionnaire, Form II): Usually higher scores mean a worse outcome
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Any changes in prescription or patient visit schedule
Time Frame: 1 year
Any changes in prescription or patient visit schedule based on remote monitoring
1 year
Out patient clinic time consumption per patient
Time Frame: 1 year
Out patient clinic time consumption per patient
1 year
Changes in CIED parameters
Time Frame: 1 year
Changes in CIED parameters during remote monitoring
1 year
Any cardiocerebrovascular events, deaths
Time Frame: 1 year
Any cardiocerebrovascular events, deaths
1 year
Admission for heart failure or any cardiovascular intervention
Time Frame: 1 year
Admission for heart failure or any cardiovascular intervention
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: YouMi Hwang, MD, PhD, The Catholic University of Korea

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2021

Primary Completion (Actual)

June 30, 2021

Study Completion (Actual)

December 31, 2022

Study Registration Dates

First Submitted

September 14, 2020

First Submitted That Met QC Criteria

September 14, 2020

First Posted (Actual)

September 21, 2020

Study Record Updates

Last Update Posted (Actual)

July 20, 2023

Last Update Submitted That Met QC Criteria

July 18, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arrhythmias, Cardiac

Clinical Trials on remote monitoring

Subscribe